Core Insights - FIGS, Inc. has experienced a significant recovery in its stock price, trading above $17, marking a nearly 260% increase over the past year, with a notable 58% rise in the last month [3][8] - Despite the positive stock performance, the consensus 12-month price target is $12.25, indicating a potential decline of almost 30% from current levels, raising questions about the sustainability of this recovery [4][8] Company Performance - The company saw a dramatic decline in stock price post-IPO, dropping below $8 within a year after debuting at $22 per share in May 2021 and reaching $50 shortly after [4][5] - Recent earnings reports have shown strong revenue growth, with Q3 2025 results leading to a stock surge of over 30% following an upbeat outlook and raised guidance for net revenue and adjusted EBITDA margins [6] - The Q4 2025 earnings report revealed a record revenue of over $200 million, a 33% increase year-over-year, with scrubwear sales up 35% and international sales increasing by 55% [7][8] Market Context - The COVID-19 pandemic initially boosted demand for medical apparel, but the stock faced challenges as the pandemic eased, leading to a prolonged period of low trading prices [5] - The recent rally in FIGS stock has been supported by strong earnings and positive analyst sentiment, with Zacks Research upgrading the stock to Strong Buy from Hold [6]

Financial Data and Key Metrics Changes - Q4 net revenues increased by 33% year-over-year, surpassing $200 million for the first time in company history [8][26] - Full year net revenues reached a record $631.1 million, an increase of 14% year-over-year [33] - Adjusted EBITDA margin for Q4 was 13.2%, compared to 13.9% in the previous year [33] - Net income for Q4 was $18.5 million, or diluted EPS of $0.10, compared to $1.9 million or diluted EPS of $0.01 last year [33] Business Line Data and Key Metrics Changes - Scrub wear surged 35%, representing 77% of net revenues for Q4 [29] - Non-scrub wear increased by 26%, accounting for 23% of net revenues [29] - Average order value (AOV) increased by 9% to $126, driven by higher average unit retail and units per transaction [27] Market Data and Key Metrics Changes - U.S. net revenues increased by 29% to $164.2 million, while international net revenues grew by 55% to $37.7 million [30] - International growth was primarily driven by existing markets, with notable performance in Canada, Mexico, and ongoing success in the Middle East and Europe [31] Company Strategy and Development Direction - The company aims to be the leading premium healthcare uniform provider globally, focusing on product innovation, community engagement, and market expansion [5][12] - Plans for 2026 include elevating core products through fabric innovation and expanding into new categories beyond scrubs [13][14] - The company is expanding its community hubs, with plans to open four new locations in 2026 [54][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position, citing strong demand for healthcare professionals and a favorable operating environment post-COVID [11][66] - The company anticipates net revenue growth of 10%-12% year-over-year for fiscal 2026, driven by sustained active customer momentum [38] - Gross margins are expected to improve modestly year-over-year, despite ongoing tariff pressures [39] Other Important Information - The company ended 2025 with a record net cash position of $300.8 million [34] - A $5.6 million inventory write-off was taken in Q4 to address older inventory issues [36] Q&A Session Summary Question: Can you talk about the flow through from the just completed Olympics and the strength of the community hubs? - Management highlighted the success of the Winter Olympics campaign and the positive impact of community hubs, with plans to open four new locations in 2026 [47][51] Question: Can you provide color on the progression of Q4 and into January, particularly in international markets? - Management noted strong momentum in international markets, particularly in Mexico and Canada, with positive indicators for Q1 [58] Question: How much of the sales acceleration is due to FIGS' specific efforts versus easing sector pressures? - Management indicated that both execution and a normalization in the industry contributed to sales acceleration [66] Question: What are the expectations around new customer growth in 2026? - Management expects continued growth in new customer acquisition, reactivation, and retention rates [85] Question: How did international margins shape up in 2025 versus the prior year? - Management confirmed that all international markets are profitable after the first year, with expectations for improved margins as the customer base matures [86]

Financial Data and Key Metrics Changes - Q4 net revenues increased by 33% year-over-year, surpassing $200 million for the first time in company history [8][26] - Full year net revenues reached a record $631.1 million, an increase of 14% year-over-year [33] - Adjusted EBITDA margin for Q4 was 13.2%, compared to 13.9% in the previous year [33] - Net income for Q4 was $18.5 million, or diluted EPS of $0.10, compared to $1.9 million or diluted EPS of $0.01 last year [33] Business Line Data and Key Metrics Changes - Scrub wear surged 35%, representing 77% of net revenues for Q4 [29] - Non-scrub wear increased by 26%, accounting for 23% of net revenues [29] - Average order value (AOV) increased by 9% to $126, driven by higher average unit retail and units per transaction [27] Market Data and Key Metrics Changes - U.S. net revenues increased by 29% to $164.2 million, while international net revenues grew by 55% to $37.7 million [30] - International growth was primarily driven by existing markets, with notable performance in Canada, Mexico, and ongoing success in the Middle East and Europe [31] Company Strategy and Development Direction - The company aims to be the leading premium healthcare uniform provider globally, focusing on product innovation, community engagement, and market expansion [5][12] - Plans for 2026 include elevating core products through fabric innovation and expanding into new categories beyond scrubs [13][14] - The company is expanding its community hubs, with plans to open four new locations in 2026, targeting larger store formats for better customer engagement [49][51] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's growth trajectory, citing strong demand for healthcare professionals and a favorable operating environment post-COVID [11][62] - The company anticipates net revenue growth of 10%-12% year-over-year for fiscal 2026, driven by sustained active customer momentum [38] - Gross margins are expected to improve modestly year-over-year, despite ongoing tariff pressures [39] Other Important Information - The company ended 2025 with a record net cash position of $300.8 million, allowing for continued investments in growth opportunities [34] - A $5.6 million inventory write-off was taken in Q4 to address older inventory, positioning the company for better inventory management moving forward [36] Q&A Session Summary Question: Can you talk about the flow through from the just completed Olympics and the strength of the community hubs? - Management highlighted the successful support of Team USA's medical team during the Winter Olympics and the positive impact of community hubs, with plans to open four new locations in 2026 [46][49] Question: Can you provide color on the progression of Q4 and into January, particularly in international markets? - Management noted strong momentum in international markets, particularly in Mexico and Canada, with positive indicators for continued growth into Q1 [55] Question: How much of the sales acceleration is due to FIGS' specific efforts versus easing sector pressures? - Management indicated that both execution and easing sector pressures contributed to sales acceleration, emphasizing the importance of product and marketing efforts [61] Question: What are the expectations around new customer growth in 2026? - Management expects continued growth in new customer acquisition, reactivation, and retention, driven by effective marketing and product strategies [80] Question: How did international margins shape up in 2025, and what are the expectations going forward? - Management confirmed that all international markets are profitable after the first year, with expectations for improved margins as the customer base shifts towards returning customers [81]

Financial Data and Key Metrics Changes - Q4 net revenues grew 33% year-over-year, reaching $201.9 million, marking the strongest quarterly growth in over four years [6][25] - Full year net revenues reached a record $631.1 million, an increase of 14% year-over-year [31] - Adjusted EBITDA for Q4 was $26.7 million, with an adjusted EBITDA margin of 13.2% compared to 13.9% last year [31] - Gross margin for Q4 contracted 440 basis points to 62.9% due to higher tariffs and a one-time benefit from duty drawback claims in the previous year [29][30] Business Line Data and Key Metrics Changes - Scrub wear surged 35%, representing 77% of net revenues for the period, while non-scrub wear increased 26%, accounting for 23% of net revenues [27] - Average order value increased 9% to $126, driven by higher average unit retail and units per transaction [26] - Active customer growth accelerated to 9% year-over-year, reaching a record of over 2.9 million active customers [26] Market Data and Key Metrics Changes - U.S. net revenues increased 29% to $164.2 million, while international net revenues grew 55% to $37.7 million [28] - International growth was primarily driven by existing markets, with notable performance in Canada, Mexico, and ongoing success in the Middle East and Europe [29] Company Strategy and Development Direction - The company aims to be the leading premium healthcare uniform provider globally, focusing on product innovation, community engagement, and market expansion [4][11] - Plans for 2026 include elevating core products through fabric innovation and expanding into new categories beyond scrubs [12][13] - The company is strategically investing in community hubs and international markets, with plans to open four new community hubs in 2026 [22][47] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position post-COVID, highlighting strong demand for healthcare professionals and the need for FIGS products [10][61] - The company anticipates net revenue growth of 10%-12% year-over-year for fiscal 2026, driven by sustained active customer momentum [35] - Management acknowledged the challenges posed by tariffs but remains optimistic about long-term growth and profitability [34][39] Other Important Information - The company ended 2025 with a record net cash position of $300.8 million, allowing for continued investment in growth opportunities [32] - A $5.6 million inventory write-off was taken in Q4 to address older inventory, positioning the company for better inventory management in 2026 [33] Q&A Session Summary Question: Can you talk about the flow through from the Olympics and the strength of community hubs? - Management highlighted the success of their Olympic campaign and the positive performance of community hubs, with plans to open four new locations in 2026 [43][47] Question: Can you provide insights on international market growth and customer response to pricing adjustments? - Management reported strong growth in international markets, particularly in Canada and Mexico, and noted that customer response to recent price adjustments has been cautiously positive [71][73] Question: What are the drivers of sequential acceleration in U.S. growth momentum? - Management indicated balanced growth across different customer cohorts, with improvements in new customer acquisition, reactivation, and retention rates [84]

Economic Indicators - The November consumer price index (CPI) report is expected to show a 12-month inflation rate of 3.1%, with a core CPI (excluding food and energy) forecasted at an annual rate of 3.0% [2] - The Bureau of Labor Statistics noted that the release will not include 1-month percent changes for November 2025 due to the cancellation of the October inflation report [3] IPO Market - Medline, a medical supply giant, had a successful IPO, with shares jumping 41% on its debut, bringing its market capitalization to approximately $54 billion after opening at $35, up from its $29 IPO price [4] - Over 200 IPOs have been priced this year despite market volatility, marking the largest U.S. listing since Rivian's $13.7 billion deal in November 2021 [5] Corporate Leadership Changes - Glen Hauenstein, president of Delta Air Lines, will retire at the end of February after 20 years with the company, during which he helped position Delta as a leader in profitability [7] - Some of Delta's strategies, such as raising entry requirements for its SkyClubs, have faced customer pushback [8]

Core Insights - Security Benefit Life Insurance Co. exited its position in FIGS, Inc., selling 565,560 shares for an estimated $3.19 million [1][2] - The sale eliminated a position that accounted for 1.51% of assets under management as of the end of the previous quarter [2] - As of November 24, 2025, FIGS shares were priced at $9.59, reflecting a 103% increase over the past year, significantly outperforming the S&P 500 by 87 percentage points [3] Company Overview - FIGS, Inc. is a healthcare apparel company focused on the direct-to-consumer segment, utilizing a digital-first approach to reach medical professionals [5] - The company offers a range of products including scrubs, lab coats, and accessories, primarily generating revenue through online sales [7] - FIGS aims to maintain its leadership in the premium medical apparel market with a scalable platform and strong presence in the U.S. healthcare sector [5] Financial Performance - For the trailing twelve months (TTM), FIGS reported revenue of $581.03 million and a net income of $17.63 million [4] - The company's stock price has seen a one-year change of 103%, indicating strong market performance [4] Market Position and Growth Potential - FIGS has a repeat sales model due to the nature of its products, which need to be continually replaced [9] - The company experienced an 8% sales growth in its last quarter, marking its highest growth in two years, although this is considered modest for a young company [10] - Currently, FIGS has a net income margin of 6%, with potential to improve towards a 15% margin, similar to peers like Lululemon [11] - Approximately 14% of FIGS' sales come from international markets, where it holds a market share of less than 1%, indicating room for growth in these regions [12]

Financial Data and Key Metrics Changes - Net revenues increased by 8% year-over-year to $151.7 million, exceeding the outlook of flat to up 2% [22][24] - Adjusted EBITDA margin improved by 900 basis points to 12.4% compared to 3.4% last year [5][29] - Gross margin expanded by 280 basis points to 69.9%, driven by lower discounts and improved return rates [27][29] Business Line Data and Key Metrics Changes - Scrubwear grew by 8%, representing 84% of net revenues, supported by effective merchandising and marketing [24][25] - Non-scrubwear increased by 7%, accounting for 16% of net revenues, with strong growth in underscrubs and shoes [24][25] - Average order value rose by 6% to $114, primarily due to a higher rate of full-price sales [23] Market Data and Key Metrics Changes - U.S. sales increased by 8% to $127.3 million, marking the strongest performance in nine quarters [25] - International net revenues grew by 12%, with notable strength in acquiring new customers [25][26] - Active customer count reached nearly 2.8 million, reflecting a 4% increase year-over-year [23] Company Strategy and Development Direction - The company is focusing on expanding its international presence, planning to increase from 33 to nearly 60 markets by year-end [15][17] - Investments are being made in product innovation, including new fabric solutions like FIBREX, aimed at enhancing product offerings [8][58] - The company is committed to maintaining a strong connection with healthcare professionals, emphasizing community engagement and brand authenticity [21][14] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the ongoing momentum into Q4, expecting it to be the strongest net revenue growth quarter of the year [5][31] - The company anticipates a full-year revenue growth of approximately 7%, up from previous low single-digit expectations [31] - Management acknowledged challenges from tariffs but highlighted successful mitigation strategies and operational efficiencies [36][37] Other Important Information - Inventory increased by 23% year-over-year to $151.2 million, attributed to deeper investments in key styles and earlier timing of in-transit inventory [29][30] - The company has $52 million available for future share repurchases under its current program [30] Q&A Session Summary Question: Can you discuss the gross margin performance this quarter? - Management noted a gross margin of 69.9%, higher than historical rates, driven by improved discount rates and returns processing [39][40] Question: What drove the demand during business-as-usual days without promotions? - Management reported acceleration in business-as-usual days, with broad-based performance across U.S. and international markets [41][42] Question: How do you see AOV contributing to revenue growth in 2026? - AOV increased by 6%, with expectations for continued growth driven by product mix and customer engagement [44][45] Question: What are the growth drivers for community hubs? - The company plans to open three new community hubs in key healthcare locations, leveraging learnings from existing stores [51][52] Question: How is the international market expected to grow? - Management expressed confidence in sustaining double-digit growth in international markets, supported by a two-pronged strategy of broad and deep market penetration [61][62]

Core Insights - Baron Focused Growth Fund reported a 4.83% appreciation in Q3 2025, underperforming the Russell 2500 Growth Index's 10.73% gain due to economic growth concerns affecting Consumer Discretionary stocks and rising competitive pressures [1] Company Highlights - FIGS, Inc. (NYSE:FIGS) achieved a one-month return of 9.22% and a 52-week gain of 13.64%, closing at $7.58 per share with a market capitalization of $1.238 billion on November 5, 2025 [2] - In Q3 2025, FIGS, Inc. shares increased by 18.6%, contributing 35 basis points to the fund's performance, driven by strong results and revenue acceleration from recent investments despite reduced promotions [3] - The company is experiencing improved purchasing patterns and margin enhancements due to better efficiency from its new fulfillment center, positioning itself to capture market share in the $80 billion global healthcare apparel industry [3] - FIGS is expected to grow its core scrubs business while expanding into retail stores, business-to-business revenue, and international markets, supported by revenue acceleration and strong cash generation [3]

Summary of Superior Group of Companies Conference Call Company Overview - **Company Name**: Superior Group of Companies (NasdaqGM: SGC) - **Date of Conference**: September 18, 2025 - **Key Speakers**: Mike Koempel (CFO), Michael Benstock (Chairman and CEO) - **Company History**: Founded over 100 years ago, with a focus on three diversified segments [2][3] Industry Segments 1. **Healthcare Apparel** - Largest provider of healthcare apparel in the U.S., serving over 12 million healthcare professionals [5][6] - Total Addressable Market (TAM) estimated at over $4 billion, with significant growth opportunities [9] - Key brands include Wink and Fashion Seal Healthcare, with a strong omnichannel distribution strategy [8][10] 2. **Branded Products** - This segment is the largest, providing promotional products and logoed uniforms to major U.S. companies [11] - The branded products industry is approximately $26 billion, with SGC ranking among the top 10 largest branded distributors [14] - Notable clients include Taco Bell, Dunkin', Tesla, Walmart, and CVS, focusing on high-quality merchandise rather than low-value items [12][13] 3. **Contact Centers (The Office Gurus)** - Operates nearshore contact centers in El Salvador, Belize, the Dominican Republic, and Florida [19][20] - Fastest growing segment with a cumulative adjusted growth of 22% through 2024 and an EBITDA margin of 12.6% [22] - Market share is minimal, focusing on small to medium-sized businesses, with a total market exceeding $100 billion in the U.S. [22] Financial Highlights - **Revenue**: Consolidated revenues were $566 million, with a CAGR of 8% since 2019 [4] - **2025 Guidance**: Projected sales range of $550 to $575 million, indicating continued growth across all segments [24] - **Balance Sheet**: Net leverage ratio improved to about 1.7 times EBITDA, with a target range of 2 to 2.5 times [37][38] - **Dividends**: Uninterrupted dividend payments since 1977, with a yield of 4% to 5% [41][42] Strategic Initiatives - **Cost-Savings Plan**: Announced a $13 million reduction in annualized budgeted expenses, with expected benefits to be fully realized by 2026 [45][46] - **AI Integration**: Implementing AI across contact center services to enhance efficiency and customer loyalty, with 35 customers already utilizing the AI stack [34][35] - **Share Repurchase Program**: Initiated in August 2024, with $15 million of stock repurchased, balancing investments and share buybacks [38] Market Dynamics - **Customer Sentiment**: Improvement noted in the second quarter of 2025, with a 14% increase in branded products sales compared to the first quarter [42] - **Tariff Impact**: Initial concerns over tariffs have subsided, leading to increased willingness among customers to proceed with purchasing decisions [42][43] - **Sales Team Expansion**: Plans to expand and upskill sales teams across all business segments in 2026 [47][48] Conclusion - Superior Group of Companies is positioned for growth across its diversified segments, with a strong focus on customer retention, strategic investments, and leveraging technology to enhance operational efficiency. The company maintains a solid financial foundation and is committed to returning value to shareholders through dividends and share repurchases.

Core Insights - The company has been a disruptor in the health care apparel market for approximately 13 years, focusing on comfort, functionality, and design [1] - The business experienced over 100% annual growth, particularly during the pandemic when demand for scrubs surged [1] - Post-pandemic, the company is positioned as a leader in the industry, offering the best products and brand [1]